Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 463 of 3330
Next
>>
>
11551 to 11575 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	0.032	uM	10999.145	0.9428	0.8512	0.7621
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	0.16	uM	10999.145	0.9960	0.9895	0.7621
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	0.8	uM	10999.145	0.8806	0.6926	0.7621
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	4	uM	10999.145	0.5716	-0.0400	0.7621
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	20	uM	10999.145	0.4898	-0.2162	0.7621
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	100	uM	10999.145	0.4896	-0.2166	0.7621
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	0.0000853	uM	12379.17	1.0063	1.0216	0.5805
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	0.000427	uM	12379.17	0.9954	0.9843	0.5805
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	0.00213	uM	12379.17	0.9947	0.9817	0.5805
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	0.0107	uM	12379.17	1.0259	1.0902	0.5805
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	0.0533	uM	12379.17	1.0833	1.2956	0.5805
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	0.267	uM	12379.17	0.9936	0.9779	0.5805
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	1.33	uM	12379.17	0.8154	0.4073	0.5805
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	6.67	uM	12379.17	0.3585	-0.6583	0.5805
MDA-MB-361	HER2amp	Luminal	Bosutinib	Src	nRTK	33.3	uM	12379.17	0.3697	-0.6398	0.5805
MDA-MB-415	HR+	Luminal	Bosutinib	Src	nRTK	0.000256	uM	10938.145	0.8123	0.6577	1.1073
MDA-MB-415	HR+	Luminal	Bosutinib	Src	nRTK	0.00128	uM	10938.145	0.7501	0.5426	1.1073
MDA-MB-415	HR+	Luminal	Bosutinib	Src	nRTK	0.0064	uM	10938.145	0.8147	0.6622	1.1073
MDA-MB-415	HR+	Luminal	Bosutinib	Src	nRTK	0.032	uM	10938.145	0.7969	0.6292	1.1073
MDA-MB-415	HR+	Luminal	Bosutinib	Src	nRTK	0.16	uM	10938.145	0.9079	0.8330	1.1073
MDA-MB-415	HR+	Luminal	Bosutinib	Src	nRTK	0.8	uM	10938.145	0.5381	0.1429	1.1073
MDA-MB-415	HR+	Luminal	Bosutinib	Src	nRTK	4	uM	10938.145	0.7493	0.5411	1.1073
MDA-MB-415	HR+	Luminal	Bosutinib	Src	nRTK	20	uM	10938.145	0.0891	-0.7748	1.1073
MDA-MB-415	HR+	Luminal	Bosutinib	Src	nRTK	100	uM	10938.145	0.5076	0.0842	1.1073
MDA-MB-415	HR+	Luminal	Bosutinib	Src	nRTK	0.0000853	uM	12333.17	0.9212	0.7689	0.6683

|<
<<
Previous
Page 463 of 3330
Next
>>
>
11551 to 11575 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)